TOP TIERMARKET NEWSWIRE
News & sentiment

KORRO BIO INC (KRRO) — News & AI sentiment

KORRO BIO INC (KRRO) news roundup. 11 stories aggregated over the last 30 days. Average 30-day sentiment is 55.4/100. Recent insider activity (SEC Form 4, 90-day window): 2 purchases totalling $964K and 6 sales totalling $1.2M — net selling of $255K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
11
avg sentiment 55.4/100
Insider net (90d)
$255K
2 buys · 6 sells
Congress (90d)
0
0 buys · 0 sells

KRRO news in the last 24 hours, 7 days, 30 days and 90 days

How much KRRO coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowKRRO storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days1155.4/100KRRO headlines →
Last 90 days2454.8/100KRRO headlines →

Latest stories on KRRO

Oct 22
Korro Bio, Inc. (KRRO) files 8-K
SEC 8-K50 · neutralgeneral
Oct 22
Oct 21
Oct 16
Oct 16
Oct 16
Oct 16
KRRO, Korro Bio | IBD Stock Checkup
Investors.com55 · neutralgeneral
Oct 6
H.C. Wainwright reiterates Korro Bio stock rating on trial dosing
Investing.com Analyst Ratings56 · neutralanalyst
Oct 6
Oct 5
Oct 5
Korro Bio, Inc. (KRRO) files 8-K
SEC 8-K50 · neutralgeneral
Oct 5
Oct 5
Oct 5
Sep 11
Sep 11
Sep 11
Aug 27
Korro to Participate in Upcoming Investor Conferences
Business Insider56 · neutralgeneral
Aug 27
Aug 20
Korro Bio, Inc. (KRRO) files 8-K
SEC 8-K50 · neutralgeneral
Aug 19
Aug 14
Aug 14
Raymond James reiterates Korro Bio stock rating on hyperammonemia outlook
Investing.com Analyst Ratings56 · neutralanalyst
Aug 7
Korro Bio GAAP EPS of -$1.07, revenue of $1.5M
Seeking Alpha28 · bearishearnings
Aug 6
Open KRRO in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →